22nd Century Group Inc (XXII) News

Pharma Stock Up Big After Second Major Announcement This Week

A New York-based pharmaceutical company is stealing the show on Wednesday following a key appointment of a new executive. According to a release...

22nd Century Appoints Larry Firestone as Chairman and CEO

BUFFALO, N.Y., Nov. 29, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (“22nd Century” or...

Form 8-K - Current report

22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise

BUFFALO, N.Y., Nov. 27, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company” or...

Form 8-K - Current report

Form 8-K - Current report

22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores

BUFFALO, N.Y., Nov. 08, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading...

22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License

BUFFALO, N.Y., Nov. 07, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading...

Form 8-K - Current report

22nd Century Group (XXII) Reports Third Quarter 2023 Financial Results

Third quarter 2023 net revenue of $17.8 millionExpanded VLN® availability to more than 4,550 stores in 19...

22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB

BUFFALO, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading...

22nd Century Group (XXII) Reduces Debt by $8.1 Million

BUFFALO, N.Y., Oct. 25, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]